State SC
Clinical Trials in South Carolina
Recruiting clinical trials with at least one study location in South Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in South Carolina
NCT07159633 N/A
Recruiting
OurRelationship-S: A Digital Relationship-Strengthening Program for Couples Expe...
Condition
Relationship Conflict
Enrollment
120 pts
Location
United States
Sponsor
OurRelationship
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
NCT05939414 Phase 3
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Obse...
Condition
Oligometastatic Prostate Cancer (OMPC)
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
NCT06205121 Phase 2
Recruiting
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidos...
Condition
Pulmonary Sarcoidosis
Enrollment
96 pts
Location
United States, Denmark, France
Sponsor
Molecure S.A.
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07400588 Phase 2
Recruiting
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus
Condition
Obese
Enrollment
50 pts
Location
United States
Sponsor
Gasherbrum Bio, Inc., a wholly
NCT06937229 Phase 3
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agi...
Condition
Alzheimer Disease
Enrollment
600 pts
Location
United States, Argentina, Brazil
Sponsor
Bristol-Myers Squibb
NCT06106672 Phase 1, Phase 2
Recruiting
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in S...
Condition
Myasthenia Gravis
Enrollment
54 pts
Location
United States
Sponsor
COUR Pharmaceutical Developmen
NCT05937672 Phase 3
Recruiting
Cold Atmospheric Plasma Device Extension Study
Condition
Verruca Vulgaris
Enrollment
40 pts
Location
United States
Sponsor
Medical University of South Ca
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT06307652 Phase 3
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...
Condition
Heart Failure and Impaired Kidney Function
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06163326 Phase 3
Recruiting
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Partici...
Condition
Vitiligo
Enrollment
400 pts
Location
United States, Australia, Bulgaria
Sponsor
Pfizer
NCT06447168 N/A
Recruiting
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in P...
Condition
Primary Biliary Cholangitis
Enrollment
424 pts
Location
United States, Austria, Canada
Sponsor
Ipsen
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, Germany
Sponsor
Boston Scientific Corporation
NCT06794996 Phase 2
Recruiting
Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or...
Condition
Proteinuric Kidney Disease
Enrollment
45 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT05730283 Phase 2
Recruiting
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
Condition
Ototoxicity, Drug-Induced
Enrollment
105 pts
Location
United States
Sponsor
Kevin Winthrop
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT00756769 N/A
Recruiting
Systemic Lupus Erythematosus in Gullah Health
Condition
Systemic Lupus Erythematosus
Enrollment
750 pts
Location
United States
Sponsor
Medical University of South Ca
NCT06904391 N/A
Recruiting
Education & Mentorship of Advanced Practice Providers to Increase Community-base...
Condition
Other
Enrollment
97 pts
Location
United States
Sponsor
Wake Forest University Health
NCT06985953 N/A
Recruiting
Evaluating the Communication Between Patients and Providers in Cancer Clinics
Condition
Cancer
Enrollment
30 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT06395753 Phase 2
Recruiting
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Condition
Prostate Cancer
Enrollment
66 pts
Location
United States, Belgium, France
Sponsor
Debiopharm International SA
NCT06999603 Phase 2
Recruiting
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respira...
Condition
Viral Pneumonia
Enrollment
550 pts
Location
United States, Belgium, France
Sponsor
Synairgen Research Ltd.
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT07323654 Phase 2
Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Sev...
Condition
Eosinophilic Asthma
Enrollment
264 pts
Location
United States
Sponsor
Kymera Therapeutics, Inc.
Page 1 of 7 — 164 trials total